FDA.reportPublic FDA data

Application 206439

Type
NDA
Sponsor
ALLERGAN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NAMZARICDONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORAL10MG;14MGYesNo
002NAMZARICDONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORAL10MG;28MGYesYes
003NAMZARICDONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORAL10MG;7MGYesNo
004NAMZARICDONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORAL10MG;21MGYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0456-1207Namzaricmemantine hydrochloride and donepezil hydrochlorideAllergan, Inc.NDACurrent
0456-1207Namzaricmemantine hydrochloride and donepezil hydrochlorideAllergan, Inc.NDACurrent
0456-1207Namzaricmemantine hydrochloride and donepezil hydrochlorideAllergan, Inc.NDACurrent
0456-1214Namzaricmemantine hydrochloride and donepezil hydrochlorideAllergan, Inc.NDACurrent
0456-1214Namzaricmemantine hydrochloride and donepezil hydrochlorideAllergan, Inc.NDACurrent
0456-1214Namzaricmemantine hydrochloride and donepezil hydrochlorideAllergan, Inc.NDACurrent
0456-1221Namzaricmemantine hydrochloride and donepezil hydrochlorideAllergan, Inc.NDACurrent
0456-1221Namzaricmemantine hydrochloride and donepezil hydrochlorideAllergan, Inc.NDACurrent
0456-1221Namzaricmemantine hydrochloride and donepezil hydrochlorideAllergan, Inc.NDACurrent
0456-1228Namzaricmemantine hydrochloride and donepezil hydrochlorideAllergan, Inc.NDACurrent
0456-1228Namzaricmemantine hydrochloride and donepezil hydrochlorideAllergan, Inc.NDACurrent
0456-1228Namzaricmemantine hydrochloride and donepezil hydrochlorideAllergan, Inc.NDACurrent
0456-1229Namzaricmemantine hydrochloride and donepezil hydrochlorideAllergan, Inc.NDACurrent
0456-1229Namzaricmemantine hydrochloride and donepezil hydrochlorideAllergan, Inc.NDACurrent
0456-1229Namzaricmemantine hydrochloride and donepezil hydrochlorideAllergan, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
19721SUPPL2016-07-21
10571SUPPL2016-07-19
43521ORIG2015-05-14
24516ORIG2015-05-14
40549ORIG2015-01-08
10570ORIG2014-12-30